Clene Inc. Common Stock

CLNNNASDAQUSD
4.44 USD
0.00 (0.00%)🟢PRE MARKET (AS OF 07:57 PM EDT)
🟢Market: OPEN

Shares of Clene Inc. Common Stock (CLNN) are trading at $4.44. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (159.5%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Aug 24, 2026.

Open?$4.31
High?$4.55
Low?$4.16
Prev. Close?$4.44
Volume?36.8K
Avg. Volume?75.2K
VWAP?$4.41
Rel. Volume?0.49x
Bid / Ask
Bid?$3.70 × 100
Ask?$5.13 × 100
Spread?$1.43
Midpoint?$4.42
Valuation & Ratios
Market Cap?57.0M
Shares Out?12.8M
Float?8.3M
Float %?70.3%
P/E Ratio?N/A
P/B Ratio?-2.30
EPS?-$3.08
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Employees
79
Market Cap
55.5M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-12-31
Address
6550 SOUTH MILLROCK DRIVE, SUITE G50
SALT LAKE CITY, UT 84121
Phone: 801-676-9695
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
50
Short Sent.?
28
Piotroski F-Score?2/9Weak
Altman Z-Score?-21.73Distress
Confidence?58%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?11.45%High
Short Interest?947.6K
Days to Cover?14.4
Free Float8.3M
Avg Daily Volume65.7K
Settlement Date2026-07-31
Financial Health
Current Ratio?3.07Strong
Quick Ratio?3.07Strong
Cash Ratio?1.99Strong
Debt/Equity?-0.76Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
S&P
97
-2.30CHEAP
P/S?
Peers
100
S&P
3
289.58HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-3.5CHEAP
EV/Sales?
Peers
100
S&P
3
335.54HIGH
Returns & Efficiency
ROE?
Peers
50
S&P
97
159.5%STRONG
ROA?
S&P
3
-171.5%WEAK
Cash Flow & Enterprise
FCF?$-15947000
Enterprise Value?$66.1M
Fundamentals ratios updated end of day